...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Biogen

ImmunoSupremo - I think a big plus for ABL is the length of time patients were on the drug durring BETonMACE, 6 to 36 months. Safe for cronic use I think were the words used. If we get an increase in cognitve function I think it will be a first historically. If that's the case it should at least raise a few eyebrows.

tada

Share
New Message
Please login to post a reply